Scarica l'app Stockscreener
16.09
5.44%
0.83
Dopo l'orario di chiusura:
16.17
0.08
+0.50%
Uniqure N V Borsa (QURE) Ultime notizie
NASDAQ: QURE: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE) - The Globe and Mail
QURE DEADLINE NOTICE: uniQure N.V. Investors Encouraged to Contact Kirby McInerney LLP By April 13, 2026 - ACCESS Newswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V.QURE - Morningstar
uniQure N.V. stock surges on positive Phase 1/ 2 data for AMT-130 in Huntington's disease - AD HOC NEWS
QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data - PR Newswire
Energy Moves: Does uniQure NV have strong fundamentals2026 Volume Leaders & Reliable Price Breakout Signals - baoquankhu1.vn
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline - GlobeNewswire Inc.
QURE INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - TMX Newsfile
uniQure N.V. $QURE Shares Sold by JPMorgan Chase & Co. - MarketBeat
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
uniQure N.V. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights - Benzinga
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline – Company AnnouncementFT.com - Financial Times
uniQure N.V. Stockholders Should Contact Robbins LLP for Information About Leading the QURE Class Action - PharmiWeb.com
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. ... - Bluefield Daily Telegraph
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming DeadlinesQURE - PR Newswire
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of ... - Bluefield Daily Telegraph
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
Uniqure NV (QURE) - MSN
QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data - PR Newswire
QURE stock crashes 32% in a week: Here's what you should know - MSN
A Huntington’s researcher on the UniQure-FDA fray - statnews.com
UniQure shares plunge 45% after FDA setback on Huntington’s gene therapy - MSN
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure LawsuitQURE - PR Newswire
UniQure NV (NASDAQ:QURE) Q4 2025 earnings call transcript - MSN
QURE Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in uniQure N.V. Securities Lawsuit -- The Gross Law Firm - Lelezard
QURE ALERT: FDA Reportedly Accuses uniQure of Pushing - GlobeNewswire
QURE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - PR Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
Holzer & Holzer, LLC Reminds Investors of April 13, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Kyndryl Holdings, Inc. (KD) and uniQure N.V. (QURE) - The Daily Tribune News
uniQure (NASDAQ:QURE) Shares Gap DownShould You Sell? - MarketBeat
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Class Action Filed Against uniQure N.V. (QURE) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
QURE INVESTOR ALERT: uniQure Faces Securities Class Action Over AMT-130 Clinical Trial DesignHagens Berman - PR Newswire
uniQure N.V. (NASDAQ:QURE) Sees Significant Growth in Short Interest - MarketBeat
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors - GlobeNewswire
Fred Alger Management LLC Acquires New Position in uniQure N.V. $QURE - MarketBeat
Darwin Global Management Ltd. Purchases New Shares in uniQure N.V. $QURE - MarketBeat
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit - GuruFocus
uniQure N.V. $QURE is Boxer Capital Management LLC's 2nd Largest Position - MarketBeat
Boone Capital Management LLC Makes New Investment in uniQure N.V. $QURE - MarketBeat
uniQure N.V. Stock (ISIN: IL0011559904) Faces Pressure Amid Gene Therapy Setbacks - AD HOC NEWS
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline - NewMediaWire
User - The Chronicle-Journal
Quinn Opportunity Partners LLC Acquires New Stake in uniQure N.V. $QURE - MarketBeat
uniQure N.V. $QURE Position Decreased by Integral Health Asset Management LLC - MarketBeat
Avoro Capital Advisors LLC Has $259.42 Million Position in uniQure N.V. $QURE - MarketBeat
QURE INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of uniQure N.V. Investors - ACCESS Newswire
uniQure N.V. Securities Fraud Class Action Result of FDA Approva - GuruFocus
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - StreetInsider
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz - GuruFocus
UniQure to rally around 92%? Here are 10 top analyst forecasts for Wednesday - MSN
QUREuniQure N.V Stock Price and Quote - Finviz
uniQure N.V.Ordinary Shares (NQ: QURE - The Chronicle-Journal
uniQure (NASDAQ:QURE) Trading Down 8.3%Here's Why - MarketBeat
Why (QURE) Price Action Is Critical for Tactical Trading - Stock Traders Daily
QURE jumps 20% – analysts upgrade stock on Huntington’s disease therapy update, retail eyes $150 - MSN
QURE Shareholder Alert: April 13, 2026 Lead Plaintiff Deadline in uniQure N.V. Securities Class ... - Bluefield Daily Telegraph
QURE Shareholder Alert: April 13, 2026 Lead Plaintiff - GlobeNewswire
Rosalind Advisors Inc. Acquires New Shares in uniQure N.V. $QURE - MarketBeat
UniQure Faces AMT-130 Scrutiny As FDA Shifts And Lawsuits Weigh - Sahm
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):